Biliary precipitation during ceftriaxone therapy: Frequency and risk factors

Turkish Journal of Pediatrics

Volumn 49, Issue 4, 2007, Pages 404-407

  Soysal, Ahmet ^a   Eraşov, Kemal ^a   Akpinar, Ihsan ^a   Bakir, Mustafa ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Biliary precipitation; Biliary sludge; Ceftriaxone therapy

Indexed keywords

CEFTRIAXONE;

ADOLESCENT; AGE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BILIARY PRECIPITATION; BILIARY SLUDGE; BILIARY TRACT DISEASE; BILIARY TRACT RADIOGRAPHY; CHILD; CHILD HEALTH CARE; CHOLELITHIASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; ECHOGRAPHY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORBIDITY; PNEUMONIA; RISK FACTOR; SEX DIFFERENCE; SINGLE DRUG DOSE; SOFT TISSUE INFECTION; TREATMENT DURATION; URINARY TRACT INFECTION;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BILE; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; CHOLELITHIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; INFANT; MALE; RISK FACTORS;

EID: 38349047066     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lee SP, Maher K, Nicholls JF. Origin and fate of biliary sludge. Gastroenterology 1988; 94: 170-176.
2. Maringhini A, Marceno MP, Lanzarone F. Sludge and stones after pregnancy. J Hepatol 1987; 5: 218-223.
3. Shfsiffman ML, Sugerman HJ, Kellum JM. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991; 86: 1000-1005.
4. Messing B, Bories C, Kuntslinger F. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 1983; 84: 1012-1019.
5. Avidsson A, Alvan G, Angelin B, Borga O, Nord CE. Ceftriaxone: renal and biliary excretion and effect on colon microflora. J Antimicrob Chemother 1982; 14: 213-217.
6. Schaad UB, Tschaeppeler H, Lentze MJ. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infest Dis 1986; 5: 708-710.
7. Schaad UB, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 1988; 2: 1411-1413.
8. Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge. Gastroenterology 1991; 100: 1665-1670.
9. Richards DM. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1984; 27: 469-527.
10. Cometta A, Gallot-Lavallee-Villars S, Iten A, et al. Incidence of gallbladder lithiasis after ceftriaxone treatment. J Antimicrob Chemother 1990; 25: 689-695.
11. Pigrau C, Pahissa A, Gropper S, Sureda D. Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet 1989; 2: 165.
12. Blais C, Duperval R. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy. Pediatr Radiol 1994; 24: 218-219.
13. Jacobs RF. Ceftriaxone-associated cholecystitis. Pediatr Infect Dis J 1988; 7: 434-436.
14. Zinberg J, Chernaik R, Coman E, Rosenblatt R, Brandt LJ. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis. Am J Gastroenterol 1991; 86: 1251-1254.
15. Schaad UB, Suter S, Gianella-Borradori A, Pfenninger J. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med 1990; 322: 141-147.
16. Kong MS, Chen CY. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children. Chang Keng I Hsueh 1996; 19: 50-54.